The aims were to assess: the prescription prevalence of anticoagulant drugs for
thromboprophylaxis (TP) in hospitalized older patients; the appropriateness of their …

Pharmacological thromboprophylaxis (TP) is known to reduce venous thromboembolism
(VTE) in medical inpatients, but the criteria for risk-driven prescription, safety and impact on …

Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the United
States. Hospitalized, medically ill older adults have increased risk; despite guidelines, data …

METHODS We conducted a retrospective cohort study using data from patients aged 70
years or older, admitted to Duke University Hospital general medicine services, between …

Venous thromboembolism (VTE) remains the number one preventable cause of hospital
acquired mortality and morbidity. Each year, more than 12 million patients are at risk for VTE …

Introduction Whether the association between hospitalization and venous thromboembolism
(VTE) is modified by the use of thromboprophylaxis in older patients remains insufficiently …

Background Hospital‐associated venous thromboembolism (HA‐VTE) can be prevented by
pharmacologic thromboprophylaxis. Thrombotic risk assessment models (RAMs) are …

Background To assess the incidence of venous thromboembolism (VTE) and bleeding
events with or without thromboprophylaxis and the associated costs in a cohort of medically …

Aim To investigate the prevalence and clinical correlates of overprescribing and
underprescribing of low molecular weight heparins (LMWHs) for thromboprophylaxis among …

Objectives To evaluate the efficacy of an intervention on the practice of venous
thromboembolism prevention. Design A multicenter, prospective, controlled, cluster …